Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hoth Therapeutics

1.16
+0.03002.65%
Volume:280.53K
Turnover:319.43K
Market Cap:15.32M
PE:-1.03
High:1.17
Open:1.13
Low:1.11
Close:1.13
Loading ...

Hoth Therapeutics Regains Compliance With Nasdaq Listing Rule

MT Newswires Live
·
24 Jan

BRIEF-Hoth Therapeutics Regains Compliance With Nasdaq Listing Requirements

Reuters
·
24 Jan

Hoth Therapeutics regains compliance with Nasdaq listing rules

TIPRANKS
·
24 Jan

Hoth Therapeutics Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
24 Jan

Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements

PR Newswire
·
24 Jan

Hoth Therapeutics Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
23 Jan

H.C. Wainwright Reaffirms Their Buy Rating on Hoth Therapeutics (HOTH)

TIPRANKS
·
23 Jan

Hoth Therapeutics Expands Intellectual Property Portfolio With Acquisition of New Patent Applications

THOMSON REUTERS
·
21 Jan

Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications

PR Newswire
·
21 Jan

Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

PR Newswire
·
17 Jan

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks
·
10 Jan

Hoth Therapeutics Shares Recover; Company Has No Plans for Offering

Dow Jones
·
09 Jan

Hoth Therapeutics Affirms No Plan to Raise Fresh Capital

MT Newswires Live
·
09 Jan

Hoth Therapeutics responds to market rumors, says no plans for offering

TIPRANKS
·
09 Jan

Hoth Therapeutics affirms no plans for public, private offering at this time

TIPRANKS
·
09 Jan

Hoth Therapeutics: Strong balance sheet includes over $10M cash, no debt

TIPRANKS
·
09 Jan

Hoth Therapeutics: Enrollment in HT-001 trial proceeding as planned

TIPRANKS
·
09 Jan

BRIEF-Hoth Therapeutics Affirms That It Has No Plans For Public Or Private Offering At This Time

Reuters
·
09 Jan

Hoth Therapeutics: Affirms That It Has No Plans for a Public or Private Offering at This Time

THOMSON REUTERS
·
09 Jan

Hoth Therapeutics Inc - Qtrly

THOMSON REUTERS
·
09 Jan